[Information on the 30th Summer Education Forum of the Safety Evaluation Study Group](1st Report) – Japanese Society for Safety Pharmacology

[Information on the 30th Summer Education Forum of the Safety Evaluation Study Group](1st report)
– Aiming for “real dual wielding” in non-clinical settings – 1. Date and time: September 8, 2022 (Thursday) 1:00 p.m. to September 10, 2022 (Saturday) 12:00 p.m. 2. Location: Web held 3. Application method: We will inform you of the details on the URL at a later date. <Special Lecture> Dr. Jun Manabe (Daiichi Sankyo Co., Ltd.)
Dr. Yoko Hirabayashi (National Institute of Health Sciences, Biosafety Research Center) This year, we will have lectures on carcinogenicity, cardiotoxicity, and the toxicity of impurities and additives by professors who are active in each specialized field, from the basics to the actual evaluation, and discuss with the participants. I would like to make it an opportunity for learning. Jun Naraoka (Chairperson, Astellas Pharma Inc.)
Izuru Miyawaki (Former Chairman Sumitomo Pharma Co., Ltd.)
Masafumi Doi (Secretary in charge, Daiichi Sankyo RD Novare Co., Ltd.)
Asuka Takumi (Secretary in charge, Ajinomoto Co., Inc.)
Akira Koda (Member, Maruho Co., Ltd.)
Takashi Tanaharu (Member, Bristol-Myers Squibb K.K.)
Satoko Harada (Member, Sanwa Kagaku Kenkyusho Co., Ltd.)
Toshinori Matsushita (Member, Shin Nippon Biomedical Laboratories, Ltd.)
Hirofumi Minomo (Forum Secretariat Shin Nippon Biomedical Laboratories, Ltd.)
See also  Tenerife pharmacists claim to be active health agents of the first order

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.